{"id":"W2592568061","doi":"10.1080/14740338.2017.1300251","title":"The safety of vedolizumab for the treatment of ulcerative colitis","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Adverse effect; Internal medicine; Placebo; Population; Natalizumab; Oncology; Gastroenterology; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002424776,0.0003414599,0.0009424723,0.0003454496,0.0002352798,0.001168048,0.0006926344,0.001977304,0.004920064],"category_scores_gemma":[0.005127498,0.0001080325,0.0007843419,0.0002943251,0.000481638,0.0007283877,0.000326931,0.002224508,0.002235093],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000854011,"about_ca_system_score_gemma":0.0009243803,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006263186,"about_ca_topic_score_gemma":0.0009668648,"domain_scores_codex":[0.9982854,0.0005562868,0.0001869219,0.0001656842,0.0007116849,0.00009405222],"domain_scores_gemma":[0.9962787,0.001300172,0.0009168056,0.00008529898,0.001272892,0.0001460753],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008190111,0.00005039032,0.0008586298,0.007781084,0.0002917838,0.0004348246,0.00006173833,0.0003895725,0.006608571,0.004176311,0.1078614,0.8706668],"study_design_scores_gemma":[0.0005623937,0.00155245,0.00506354,0.008178076,0.0005825887,0.003285531,0.00007789548,0.0007009737,0.004749954,0.006258445,0.9689389,0.00004923049],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004140212,0.9327537,0.002551383,0.0419194,0.004708703,0.00006136868,0.0003749545,0.00008249746,0.01340772],"genre_scores_gemma":[0.08984351,0.8476332,0.002803315,0.03377158,0.01656928,0.0001534518,0.000876039,0.00005563315,0.008293944],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004920064,"threshold_uncertainty_score":0.01645929,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04964723140641666,"score_gpt":0.372528495254814,"score_spread":0.3228812638483973,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}